NIH-backed researchers create first atlas of senescent cells across body

A new NIH-backed map of senescent cells is aimed at a problem that has slowed aging research for years: the same cells can help wounds heal and suppress tumors, yet also build up with age and drive chronic disease. The work does not deliver a treatment, but it gives scientists a sharper way to tell which senescent cells may be worth targeting and which may need to be preserved.

The National Institutes of Health said the papers published in Cell on June 11 formed the first comprehensive atlas of senescent cells across the human body. The effort came out of the Cellular Senescence Network, known as SenNet, which the NIH Common Fund launched in 2021 to identify and characterize differences in senescent cells across the body, across health states and across the lifespan. SenNet was created because these cells are rare, diverse and hard to pin down as they change by tissue and disease state.

That complexity is now central to the new framework. The consortium introduced a classification system called senotypes, grouping senescent cells by their tissue location and the conditions around them. NIH says the approach reflects a basic biological fact: senescent cells do not behave the same way in every organ, and they can look different depending on health status and local environment. In practice, that matters because researchers have long worried that one-size-fits-all strategies could damage useful cells while missing harmful ones.

NIH Deputy Director Nicole Kleinstreuer said the mapping effort is meant to build a more complete picture of senescent cells and support therapies that hit dangerous cells while sparing beneficial ones. That distinction matters because senescent cells are not simply dead debris. In healthy tissue, they can aid wound healing and help prevent tumor growth. Normally the immune system clears them, but as immune function declines with age, they can accumulate and are thought to contribute to inflammation and age-related disease.

SenNet says it is also building publicly accessible atlases of senescent cells, the differences among them and the molecules they secrete. The program builds on earlier NIH single-cell efforts, including the Human Biomolecular Atlas Program and the Single Cell Analysis Program, and has been meeting for years as the work matured, with a kickoff meeting on November 4 and 5, 2021 and a June 10-12, 2026 scientific accomplishments meeting in Washington, D.C. The broader significance is practical rather than rhetorical: the atlas gives aging, cancer and drug-development researchers a more precise starting point, even as the bigger promise of extending healthy lifespan remains far beyond a single paper.